Skip to main content

QHSLab, Inc.

corporate_fare Company Profile

QHSLab, Inc.

USAQ·OTC·Industrial Applications And Services·CIK 0000856984

QHSLab, Inc. is a digital health company that helps independent primary care practices identify, document, and manage underdiagnosed and undertreated behavioral health conditions, referred to as behavioral vital signs. This is achieved through workflow-integrated digital screening and non-face-to-face follow-up care. The company's platform supports population-based screening, patient education, and follow-up care management activities that occur outside of traditional in-office visits. QHSLab generates revenue primarily from recurring per-patient, per-month fees paid by participating medical practices for access to and use of its digital platform and associated services. The platform supports reimbursable clinical activities such as digital assessments, asynchronous interactions, and care management services, which practices can bill according to payer rules. In addition to its digital health platform, QHSLab offers an allergy diagnostics and treatment service line under the AllergiEnd® brand. This product is designed to work with the digital platform, allowing primary care practices to identify and manage allergic disease within their setting. The QHSLab Digital Platform integrates into a medical practice's existing clinical workflow, supporting structured screening, automated documentation, and digital follow-up while minimizing disruption. Its core capabilities include digital health assessments administered prior to or outside of office visits, adaptive assessment logic, identification of clinical risk factors and patient interest in care, imminent risk alerts with instructions, automated generation of patient and provider reports, delivery of provider reports into the practice's electronic health record (EHR), ongoing digital follow-up, education, periodic patient check-ins, and support for non-face-to-face and care management workflows. The platform is modular and extensible, allowing for future additions of new clinical domains and assessment variables. QHSLab's care model is structured around a repeatable patient journey applicable across large patient populations.

QHSLab, Inc. (OTC:USAQ) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 10 items for USAQ at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for USAQ spans 10-Q, 8-K, SCHEDULE 13D.

Recent high-impact activity:

  • QHSLab Q3: Going Concern Reaffirmed as Cash Falls to $190K and Revenue Slips 8%
  • QHSLab Swings to Q2 Profit as ISP Revenue Doubles, but Going Concern Warning Persists
  • QHSLab Swings to Q2 Profit as ISP Revenue Surges 86%
  • QHSLab Reports Q2 2026: ISP Revenue Doubles, Swings to Net Profit
  • QHSLab Presents Audited 2025 Results and Growth Strategy at MicroCap Conference

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.69M
Net Income
$457.42K
Diluted EPS
$0.02
Op. Cash Flow
$178.12K
Gross Profit
$1.81M
Operating Income
$131.24K
Cash & Equivalents
$636.16K
Debt / Equity
0.00×
Net Margin
17.0%
Shares Outstanding
15.03M sh
Source: 10-K · filed 2026-03-30 · accession 0001493152-26-013513

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 897 shares in USAQ as of the October 30, 2026 settlement, a 0.5% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 18, 2026, 82.2% of USAQ volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)897 shares as of October 30, 2026
Change vs prior period▼ 0.5%
Days to cover1.00 at avg daily volume of 4,046
Daily short volume (FINRA facilities)82.2% of 13,318 shares on November 18, 2026
3-day average short volume38.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with U →
$0.259 -4.37% today
52-week range · as of 2026-11-12 $0.08 – $1.14
Market cap
$3.89M
Volume
13.3K (2.5× avg)
3-mo avg 5.4K
Live data · 2026-11-21 16:00 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed USAQ - Latest Insights

USAQ
Nov 12, 2026, 5:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.366643
Real-time Price: $0.259 info
Change: -$0.107643 (-29%) info
Market Cap: $3.893M info
USAQ
Aug 12, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.350
Real-time Price: $0.259 info
Change: -$0.091 (-26%) info
Market Cap: $3.893M info
USAQ
Aug 03, 2026, 8:40 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.233
Real-time Price: $0.259 info
Change: +$0.026 (+11%) info
Market Cap: $3.893M info
USAQ
Aug 03, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.233
Real-time Price: $0.259 info
Change: +$0.026 (+11%) info
Market Cap: $3.893M info
USAQ
Jun 17, 2026, 1:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.350
Real-time Price: $0.259 info
Change: -$0.091 (-26%) info
Market Cap: $3.893M info
USAQ
May 26, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.520
Real-time Price: $0.259 info
Change: -$0.261 (-50%) info
Market Cap: $3.893M info
USAQ
May 14, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.54875
Real-time Price: $0.259 info
Change: -$0.28975 (-53%) info
Market Cap: $3.893M info
USAQ
Apr 27, 2026, 3:36 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $0.660
Real-time Price: $0.259 info
Change: -$0.401 (-61%) info
Market Cap: $3.893M info
USAQ
Apr 21, 2026, 9:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.600
Real-time Price: $0.259 info
Change: -$0.341 (-57%) info
Market Cap: $3.893M info
USAQ
Mar 31, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.570
Real-time Price: $0.259 info
Change: -$0.311 (-55%) info
Market Cap: $3.893M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets